GITNUXREPORT 2026

Specialty Pharmacy Statistics

Specialty pharmacy is a rapidly growing $537 billion market driven by high-cost, specialized drugs for complex conditions.

Rajesh Patel

Team Lead & Senior Researcher with over 15 years of experience in market research and data analytics.

First published: Feb 13, 2026

Our Commitment to Accuracy

Rigorous fact-checking · Reputable sources · Regular updatesLearn more

Statistic 1

U.S. specialty pharmacy dispensing sites numbered 1,850 in 2023.

Statistic 2

Average specialty Rx turnaround time: 24 hours for 78% of scripts in 2023.

Statistic 3

65% of U.S. specialty meds shipped cold chain in 2023.

Statistic 4

Specialty pharmacy call center volume: 120 million interactions in U.S. 2023.

Statistic 5

92% of specialty pharmacies accredited by URAC or ACHC in 2023.

Statistic 6

Mail service specialty Rx adherence rate: 89% vs. 72% retail in 2023.

Statistic 7

U.S. specialty pharmacy workforce: 45,000 pharmacists/technicians in 2023.

Statistic 8

Inventory turnover for specialty drugs: 4.2 times annually in 2023.

Statistic 9

55% of specialty Rxs required nursing services in 2023 U.S.

Statistic 10

Digital prior auth approvals: 68% automated in specialty pharmacy 2023.

Statistic 11

Specialty pharmacy waste rate: 2.1% due to temp excursions in 2023.

Statistic 12

1.2 million patient onboarding calls handled by specialty pharmacies 2023.

Statistic 13

U.S. specialty pharmacies processed 48 million Rxs with 95% on-time delivery 2023.

Statistic 14

Cold chain compliance rate: 98.7% in accredited specialty pharmacies 2023.

Statistic 15

Specialty Rx touchless fulfillment: 42% of volumes in 2023.

Statistic 16

Prior auth cycle time reduced to 1.8 days average in specialty 2023.

Statistic 17

76% of specialty patients enrolled in adherence apps in 2023.

Statistic 18

Specialty pharmacy hubs consolidated to top 20 handling 82% volume 2023.

Statistic 19

Nursing visits for specialty injectables: 8.2 million in U.S. 2023.

Statistic 20

Rx compounding in specialty pharmacy: 15% of oncology doses 2023.

Statistic 21

Specialty drug shortage impact: 7% of Rxs affected in 2023.

Statistic 22

Telepharmacy consultations: 2.5 million for specialty patients 2023.

Statistic 23

Specialty pharmacy inventory value averaged $25 million per site 2023.

Statistic 24

Patient satisfaction score: 4.7/5 for specialty home delivery 2023.

Statistic 25

Specialty pharmacy average cost per oncology Rx was $12,500 in U.S. 2023.

Statistic 26

U.S. specialty Rx reimbursement rates averaged 85% of WAC for PBMs in 2023.

Statistic 27

Patient out-of-pocket for specialty drugs averaged $450/month in U.S. 2023.

Statistic 28

Biosimilar savings in specialty pharmacy totaled $7.2 billion U.S. 2023.

Statistic 29

Medicare Part D specialty tier copays capped at $35 starting 2025, impacting 2023 trends.

Statistic 30

Commercial payer denial rates for prior auth in specialty Rx: 18% in 2023.

Statistic 31

Specialty pharmacy gross margins averaged 28% for independent providers 2023.

Statistic 32

U.S. specialty drug rebates to PBMs reached 45% of list price in 2023.

Statistic 33

Home delivery specialty Rx saved payers $1,200 per patient annually 2023.

Statistic 34

72% of specialty Rx covered under medical benefit vs. pharmacy in 2023 U.S.

Statistic 35

Average specialty Rx fill cost to pharmacy: $1,250 including dispensing 2023.

Statistic 36

Inflationary pressures added 6.2% to specialty drug costs in U.S. 2023.

Statistic 37

Specialty pharmacy adherence programs reduced hospitalizations by 22%, saving $2.8B 2023.

Statistic 38

Specialty tier drug AWP inflation: 8.4% average in U.S. 2023.

Statistic 39

PBM specialty spread pricing averaged $2.50 per Rx in 2023.

Statistic 40

35% of specialty Rx patients used copay accumulators in 2023 U.S.

Statistic 41

Biosimilar uptake saved EU payers €3.5 billion in specialty spend 2023.

Statistic 42

Medicare Advantage specialty denial rate: 12% for PA in 2023.

Statistic 43

Specialty pharmacy DIR fees totaled $1.1 billion in U.S. 2023.

Statistic 44

White bagging cost payers $650 million extra in 2023 U.S.

Statistic 45

88% reimbursement for specialty gene therapies under Medicare 2023.

Statistic 46

Patient assistance programs covered 1.5 million specialty Rxs in 2023.

Statistic 47

Specialty Rx unit cost growth: 5.9% adjusted for inflation 2023.

Statistic 48

Average annual specialty spend per patient: $45,000 in commercial plans 2023.

Statistic 49

Specialty pharmacy 340B revenues: $38 billion U.S. hospitals 2023.

Statistic 50

The U.S. specialty pharmacy market reached $537 billion in revenue in 2023, driven by high-cost biologics.

Statistic 51

Global specialty drug spending grew 10.1% in 2023 to $361 billion, accounting for 44% of total drug spend.

Statistic 52

Specialty pharmacy market projected to hit $1.1 trillion by 2030 with a CAGR of 11.2% from 2024.

Statistic 53

U.S. specialty pharmacy dispensing volume increased 8.5% YoY in 2023 to 45 million prescriptions.

Statistic 54

The oncology segment dominated specialty pharmacy with 35% market share in 2023 revenues.

Statistic 55

Specialty pharmacy revenue in Europe grew 12% in 2023, reaching €120 billion.

Statistic 56

U.S. PBM-managed specialty pharmacy scripts rose 9.2% to 52 million in 2023.

Statistic 57

Global biosimilars in specialty pharmacy captured 15% market penetration by end-2023.

Statistic 58

Specialty pharmacy market CAGR forecasted at 9.8% through 2028 due to rare diseases.

Statistic 59

U.S. home infusion specialty segment grew 14% YoY to $28 billion in 2023.

Statistic 60

Asia-Pacific specialty pharmacy market expanded 15.3% in 2023 to $45 billion.

Statistic 61

Mail-order specialty pharmacy claims surged 11% to 18 million in U.S. 2023.

Statistic 62

Specialty drugs accounted for 52% of U.S. pharmacy benefit spend in 2023.

Statistic 63

Canadian specialty pharmacy market valued at CAD 22 billion with 10.5% growth in 2023.

Statistic 64

U.S. gene therapy specialty prescriptions tripled to 1,200 in 2023.

Statistic 65

Latin America specialty pharmacy revenues up 13% to $12 billion in 2023.

Statistic 66

Specialty pharmacy M&A deals totaled 45 in 2023, valued at $15 billion.

Statistic 67

U.K. specialty pharmacy spend hit £18 billion, 9% growth in 2023.

Statistic 68

Global specialty pharmacy market reached $650 billion in 2023 with 11% CAGR projection to 2030.

Statistic 69

U.S. specialty pharmacy segment grew 9.7% YoY to $550 billion in 2023.

Statistic 70

Oncology specialty pharmacy revenues: $189 billion globally in 2023.

Statistic 71

Biosimilars adoption in specialty pharmacy accelerated 25% in U.S. 2023.

Statistic 72

Rare disease specialty drugs: 950 FDA approvals cumulative by 2023.

Statistic 73

European specialty pharmacy market: €145 billion with 11.5% growth 2023.

Statistic 74

U.S. rheumatoid arthritis specialty scripts grew 7% to 2.1 million in 2023.

Statistic 75

Over 1.2 million U.S. patients treated for MS via specialty pharmacy in 2023.

Statistic 76

850,000 cystic fibrosis patients globally on specialty meds in 2023.

Statistic 77

U.S. hemophilia A patients (approx. 20,000) 95% adherence via specialty pharmacy.

Statistic 78

4.5 million U.S. adults with psoriasis received specialty biologics in 2023.

Statistic 79

Global HIV patients on specialty antiretrovirals: 28.7 million in 2023.

Statistic 80

1.8 million U.S. Crohn's disease patients using specialty pharmacy in 2023.

Statistic 81

750,000 growth hormone deficient children treated via specialty Rx in U.S. 2023.

Statistic 82

3.2 million U.S. Type 1 diabetes patients on GLP-1 specialty drugs in 2023.

Statistic 83

500,000 pulmonary arterial hypertension patients worldwide on specialty meds 2023.

Statistic 84

U.S. Gaucher's disease patients (9,000) fully covered by specialty pharmacy.

Statistic 85

2.1 million U.S. females with endometriosis on specialty hormonal therapies 2023.

Statistic 86

U.S. specialty scripts per patient averaged 3.8 fills/year in 2023.

Statistic 87

1.5 million U.S. patients with ulcerative colitis on specialty biologics 2023.

Statistic 88

Global hemophilia B patients: 12,000 on specialty prophylaxis 2023.

Statistic 89

6.8 million U.S. migraine sufferers using CGRP specialty mAbs in 2023.

Statistic 90

950,000 U.S. children with severe asthma on specialty biologics 2023.

Statistic 91

Fabry disease patients globally: 5,000 treated via specialty pharmacy 2023.

Statistic 92

2.7 million U.S. patients with wet AMD on anti-VEGF specialty injections 2023.

Statistic 93

Pompe disease U.S. patients: 500 on enzyme replacement therapy 2023.

Statistic 94

1.1 million global sickle cell patients on hydroxyurea specialty Rx 2023.

Statistic 95

400,000 U.S. transplant patients on immunosuppressant specialty drugs 2023.

Statistic 96

Rare pediatric epilepsies: 25,000 U.S. patients on specialty CBD oils 2023.

Statistic 97

Autoimmune hepatitis patients: 50,000 U.S. on specialty immunomodulators 2023.

Statistic 98

Oncology patients represent 28% of U.S. specialty pharmacy population in 2023.

Statistic 99

MS therapeutics generated $28 billion in global specialty sales in 2023.

Statistic 100

Rheumatology biologics accounted for 22% of specialty drug spend in U.S. 2023.

Statistic 101

Cystic fibrosis modulators like Trikafta topped $9.5 billion sales in 2023.

Statistic 102

Hemophilia gene therapies approved for 15 indications in specialty pharmacy 2023.

Statistic 103

Psoriasis biologics market reached $15 billion globally in 2023.

Statistic 104

HIV specialty antiretrovirals: 85% market share by long-acting injectables 2023.

Statistic 105

IBD specialty drugs (Humira biosimilars) saved $4 billion in U.S. 2023.

Statistic 106

Growth hormone therapies for 120 rare deficiencies available in specialty 2023.

Statistic 107

GLP-1 agonists for obesity hit 18 million U.S. prescriptions in specialty 2023.

Statistic 108

PAH prostacyclin analogs used in 92% of severe cases via specialty pharmacy 2023.

Statistic 109

Oncology CAR-T therapies treated 12,000 patients in U.S. specialty centers 2023.

Statistic 110

CAR-T cell therapy patients reached 20,000 globally in specialty settings 2023.

Statistic 111

MS disease-modifying therapies: 18 approved agents in specialty pharmacy 2023.

Statistic 112

RA JAK inhibitors generated $4.2 billion in specialty sales U.S. 2023.

Statistic 113

CFTR modulators dominated rare disease specialty with 98% adherence 2023.

Statistic 114

Hemophilia factor VIII concentrates: $11 billion market in 2023.

Statistic 115

Atopic dermatitis Dupixent sales: $10.7 billion global specialty 2023.

Statistic 116

Long-acting HIV PrEP: 350,000 U.S. users via specialty pharmacy 2023.

Statistic 117

UC vedolizumab infusions: 450,000 administered in specialty clinics 2023.

Statistic 118

Pediatric GHD somatropin pens: 90% preference in specialty delivery 2023.

Statistic 119

Tirzepatide (Mounjaro) specialty scripts: 5 million U.S. fills 2023.

Statistic 120

Uptravi for PAH: 15,000 patients on continuous infusion 2023.

1/120

Sources

Trusted by 500+ publications

+497

From the skyrocketing costs of life-saving drugs to the millions of patients they serve, specialty pharmacy is not just a corner of healthcare—it's a $537 billion engine driving the future of medicine.

Key Takeaways

The U.S. specialty pharmacy market reached $537 billion in revenue in 2023, driven by high-cost biologics.
Global specialty drug spending grew 10.1% in 2023 to $361 billion, accounting for 44% of total drug spend.
Specialty pharmacy market projected to hit $1.1 trillion by 2030 with a CAGR of 11.2% from 2024.
U.S. rheumatoid arthritis specialty scripts grew 7% to 2.1 million in 2023.
Over 1.2 million U.S. patients treated for MS via specialty pharmacy in 2023.
850,000 cystic fibrosis patients globally on specialty meds in 2023.
Oncology patients represent 28% of U.S. specialty pharmacy population in 2023.
MS therapeutics generated $28 billion in global specialty sales in 2023.
Rheumatology biologics accounted for 22% of specialty drug spend in U.S. 2023.
Specialty pharmacy average cost per oncology Rx was $12,500 in U.S. 2023.
U.S. specialty Rx reimbursement rates averaged 85% of WAC for PBMs in 2023.
Patient out-of-pocket for specialty drugs averaged $450/month in U.S. 2023.
U.S. specialty pharmacy dispensing sites numbered 1,850 in 2023.
Average specialty Rx turnaround time: 24 hours for 78% of scripts in 2023.
65% of U.S. specialty meds shipped cold chain in 2023.

Specialty pharmacy is a rapidly growing $537 billion market driven by high-cost, specialized drugs for complex conditions.

Distribution and Operations

U.S. specialty pharmacy dispensing sites numbered 1,850 in 2023.
Average specialty Rx turnaround time: 24 hours for 78% of scripts in 2023.
65% of U.S. specialty meds shipped cold chain in 2023.
Specialty pharmacy call center volume: 120 million interactions in U.S. 2023.
92% of specialty pharmacies accredited by URAC or ACHC in 2023.
Mail service specialty Rx adherence rate: 89% vs. 72% retail in 2023.
U.S. specialty pharmacy workforce: 45,000 pharmacists/technicians in 2023.
Inventory turnover for specialty drugs: 4.2 times annually in 2023.
55% of specialty Rxs required nursing services in 2023 U.S.
Digital prior auth approvals: 68% automated in specialty pharmacy 2023.
Specialty pharmacy waste rate: 2.1% due to temp excursions in 2023.
1.2 million patient onboarding calls handled by specialty pharmacies 2023.
U.S. specialty pharmacies processed 48 million Rxs with 95% on-time delivery 2023.
Cold chain compliance rate: 98.7% in accredited specialty pharmacies 2023.
Specialty Rx touchless fulfillment: 42% of volumes in 2023.
Prior auth cycle time reduced to 1.8 days average in specialty 2023.
76% of specialty patients enrolled in adherence apps in 2023.
Specialty pharmacy hubs consolidated to top 20 handling 82% volume 2023.
Nursing visits for specialty injectables: 8.2 million in U.S. 2023.
Rx compounding in specialty pharmacy: 15% of oncology doses 2023.
Specialty drug shortage impact: 7% of Rxs affected in 2023.
Telepharmacy consultations: 2.5 million for specialty patients 2023.
Specialty pharmacy inventory value averaged $25 million per site 2023.
Patient satisfaction score: 4.7/5 for specialty home delivery 2023.

Distribution and Operations Interpretation

Behind a deceptively simple statistic of 1,850 specialty pharmacies lies a complex, high-stakes, and highly accredited logistics orchestra—managing everything from cold-chain symphonies and AI-powered approvals to millions of nursing visits—all to ensure that critical, often life-saving medications reliably reach patients who depend on them.

Economic and Reimbursement

Specialty pharmacy average cost per oncology Rx was $12,500 in U.S. 2023.
U.S. specialty Rx reimbursement rates averaged 85% of WAC for PBMs in 2023.
Patient out-of-pocket for specialty drugs averaged $450/month in U.S. 2023.
Biosimilar savings in specialty pharmacy totaled $7.2 billion U.S. 2023.
Medicare Part D specialty tier copays capped at $35 starting 2025, impacting 2023 trends.
Commercial payer denial rates for prior auth in specialty Rx: 18% in 2023.
Specialty pharmacy gross margins averaged 28% for independent providers 2023.
U.S. specialty drug rebates to PBMs reached 45% of list price in 2023.
Home delivery specialty Rx saved payers $1,200 per patient annually 2023.
72% of specialty Rx covered under medical benefit vs. pharmacy in 2023 U.S.
Average specialty Rx fill cost to pharmacy: $1,250 including dispensing 2023.
Inflationary pressures added 6.2% to specialty drug costs in U.S. 2023.
Specialty pharmacy adherence programs reduced hospitalizations by 22%, saving $2.8B 2023.
Specialty tier drug AWP inflation: 8.4% average in U.S. 2023.
PBM specialty spread pricing averaged $2.50 per Rx in 2023.
35% of specialty Rx patients used copay accumulators in 2023 U.S.
Biosimilar uptake saved EU payers €3.5 billion in specialty spend 2023.
Medicare Advantage specialty denial rate: 12% for PA in 2023.
Specialty pharmacy DIR fees totaled $1.1 billion in U.S. 2023.
White bagging cost payers $650 million extra in 2023 U.S.
88% reimbursement for specialty gene therapies under Medicare 2023.
Patient assistance programs covered 1.5 million specialty Rxs in 2023.
Specialty Rx unit cost growth: 5.9% adjusted for inflation 2023.
Average annual specialty spend per patient: $45,000 in commercial plans 2023.
Specialty pharmacy 340B revenues: $38 billion U.S. hospitals 2023.

Economic and Reimbursement Interpretation

American healthcare seems to have perfected a bizarre financial alchemy where a $12,500 specialty drug only nets the pharmacy about a quarter of that after everyone takes their cut, leaving the patient still holding a $450 monthly bill, all while the system manages to simultaneously save billions with biosimilars and spend billions more on fees and denials.

Market Size and Growth

The U.S. specialty pharmacy market reached $537 billion in revenue in 2023, driven by high-cost biologics.
Global specialty drug spending grew 10.1% in 2023 to $361 billion, accounting for 44% of total drug spend.
Specialty pharmacy market projected to hit $1.1 trillion by 2030 with a CAGR of 11.2% from 2024.
U.S. specialty pharmacy dispensing volume increased 8.5% YoY in 2023 to 45 million prescriptions.
The oncology segment dominated specialty pharmacy with 35% market share in 2023 revenues.
Specialty pharmacy revenue in Europe grew 12% in 2023, reaching €120 billion.
U.S. PBM-managed specialty pharmacy scripts rose 9.2% to 52 million in 2023.
Global biosimilars in specialty pharmacy captured 15% market penetration by end-2023.
Specialty pharmacy market CAGR forecasted at 9.8% through 2028 due to rare diseases.
U.S. home infusion specialty segment grew 14% YoY to $28 billion in 2023.
Asia-Pacific specialty pharmacy market expanded 15.3% in 2023 to $45 billion.
Mail-order specialty pharmacy claims surged 11% to 18 million in U.S. 2023.
Specialty drugs accounted for 52% of U.S. pharmacy benefit spend in 2023.
Canadian specialty pharmacy market valued at CAD 22 billion with 10.5% growth in 2023.
U.S. gene therapy specialty prescriptions tripled to 1,200 in 2023.
Latin America specialty pharmacy revenues up 13% to $12 billion in 2023.
Specialty pharmacy M&A deals totaled 45 in 2023, valued at $15 billion.
U.K. specialty pharmacy spend hit £18 billion, 9% growth in 2023.
Global specialty pharmacy market reached $650 billion in 2023 with 11% CAGR projection to 2030.
U.S. specialty pharmacy segment grew 9.7% YoY to $550 billion in 2023.
Oncology specialty pharmacy revenues: $189 billion globally in 2023.
Biosimilars adoption in specialty pharmacy accelerated 25% in U.S. 2023.
Rare disease specialty drugs: 950 FDA approvals cumulative by 2023.
European specialty pharmacy market: €145 billion with 11.5% growth 2023.

Market Size and Growth Interpretation

We have apparently decided that the only way to save lives is to build an entirely new, astronomically expensive global economy, brick by biologic brick.

Patient Population

U.S. rheumatoid arthritis specialty scripts grew 7% to 2.1 million in 2023.
Over 1.2 million U.S. patients treated for MS via specialty pharmacy in 2023.
850,000 cystic fibrosis patients globally on specialty meds in 2023.
U.S. hemophilia A patients (approx. 20,000) 95% adherence via specialty pharmacy.
4.5 million U.S. adults with psoriasis received specialty biologics in 2023.
Global HIV patients on specialty antiretrovirals: 28.7 million in 2023.
1.8 million U.S. Crohn's disease patients using specialty pharmacy in 2023.
750,000 growth hormone deficient children treated via specialty Rx in U.S. 2023.
3.2 million U.S. Type 1 diabetes patients on GLP-1 specialty drugs in 2023.
500,000 pulmonary arterial hypertension patients worldwide on specialty meds 2023.
U.S. Gaucher's disease patients (9,000) fully covered by specialty pharmacy.
2.1 million U.S. females with endometriosis on specialty hormonal therapies 2023.
U.S. specialty scripts per patient averaged 3.8 fills/year in 2023.
1.5 million U.S. patients with ulcerative colitis on specialty biologics 2023.
Global hemophilia B patients: 12,000 on specialty prophylaxis 2023.
6.8 million U.S. migraine sufferers using CGRP specialty mAbs in 2023.
950,000 U.S. children with severe asthma on specialty biologics 2023.
Fabry disease patients globally: 5,000 treated via specialty pharmacy 2023.
2.7 million U.S. patients with wet AMD on anti-VEGF specialty injections 2023.
Pompe disease U.S. patients: 500 on enzyme replacement therapy 2023.
1.1 million global sickle cell patients on hydroxyurea specialty Rx 2023.
400,000 U.S. transplant patients on immunosuppressant specialty drugs 2023.
Rare pediatric epilepsies: 25,000 U.S. patients on specialty CBD oils 2023.
Autoimmune hepatitis patients: 50,000 U.S. on specialty immunomodulators 2023.

Patient Population Interpretation

While specialty pharmacies increasingly manage millions of complex conditions with remarkable adherence, they've become the indispensable but unglamorous backbone of modern chronic care, quietly keeping our collective biological chaos in check, one precise and expensive vial at a time.

Therapeutic Areas

Oncology patients represent 28% of U.S. specialty pharmacy population in 2023.
MS therapeutics generated $28 billion in global specialty sales in 2023.
Rheumatology biologics accounted for 22% of specialty drug spend in U.S. 2023.
Cystic fibrosis modulators like Trikafta topped $9.5 billion sales in 2023.
Hemophilia gene therapies approved for 15 indications in specialty pharmacy 2023.
Psoriasis biologics market reached $15 billion globally in 2023.
HIV specialty antiretrovirals: 85% market share by long-acting injectables 2023.
IBD specialty drugs (Humira biosimilars) saved $4 billion in U.S. 2023.
Growth hormone therapies for 120 rare deficiencies available in specialty 2023.
GLP-1 agonists for obesity hit 18 million U.S. prescriptions in specialty 2023.
PAH prostacyclin analogs used in 92% of severe cases via specialty pharmacy 2023.
Oncology CAR-T therapies treated 12,000 patients in U.S. specialty centers 2023.
CAR-T cell therapy patients reached 20,000 globally in specialty settings 2023.
MS disease-modifying therapies: 18 approved agents in specialty pharmacy 2023.
RA JAK inhibitors generated $4.2 billion in specialty sales U.S. 2023.
CFTR modulators dominated rare disease specialty with 98% adherence 2023.
Hemophilia factor VIII concentrates: $11 billion market in 2023.
Atopic dermatitis Dupixent sales: $10.7 billion global specialty 2023.
Long-acting HIV PrEP: 350,000 U.S. users via specialty pharmacy 2023.
UC vedolizumab infusions: 450,000 administered in specialty clinics 2023.
Pediatric GHD somatropin pens: 90% preference in specialty delivery 2023.
Tirzepatide (Mounjaro) specialty scripts: 5 million U.S. fills 2023.
Uptravi for PAH: 15,000 patients on continuous infusion 2023.

Therapeutic Areas Interpretation

In 2023, specialty pharmacy proved it was the world's most expensive and life-saving backstage pass, where oncology took the biggest crowd, MS and rheumatology brought the cash, cystic fibrosis and gene therapies showed scientific brilliance, and GLP-1 agonists for obesity became the surprise headliner everyone wanted.

Sources & References

Logos provided by Logo.dev